German pharmaceutical company Boehringer Ingelheim is partnering with medication management platform Medisafe to integrate specific information about anticoagulant medication Pradaxa in its app. The move follows a successful pilot and will offer Pradaxa patients in the US access to features including adherence and biometric tracking and Medisafe's alert service MedFriend. In addition to helping users manage their blood pressure medication, the app also provides data on other medications that are used for cardiovascular disease prevention or treatment.
German pharmaceutical company Boehringer Ingelheim is partnering with medication management platform Medisafe to integrate specific information about anticoagulant medication Pradaxa in its app. The move follows a successful pilot and will offer Pradaxa patients in the US access to features including adherence and biometric tracking and Medisafe's alert service MedFriend. The agreement follows a similar partnership with Merck that's being rolling out in Brazil, Mexico and Russia.